Risk of Upper Gastrointestinal Hemorrhage in Warfarin Users Treated With Nonselective NSAIDs or COX-2 Inhibitors | Zendy

Marisa Battistella | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of Upper Gastrointestinal Hemorrhage in Warfarin Users Treated With Nonselective NSAIDs or COX-2 Inhibitors

Author(s) -

Marisa Battistella

Publication year - 2005

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.165.2.189

Subject(s) - medicine , warfarin , rofecoxib , concomitant , celecoxib , odds ratio , upper gastrointestinal bleeding , lower risk , confidence interval , relative risk , surgery , gastroenterology , cyclooxygenase , atrial fibrillation , biochemistry , chemistry , endoscopy , enzyme

Little is known about the risk of upper gastrointestinal (GI) hemorrhage during the concomitant use of warfarin and selective cyclooxygenase (COX)-2 inhibitors. We examined the association between the concomitant use of warfarin and nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) or selective COX-2 inhibitors in older adults hospitalized for upper GI hemorrhage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research